Literature DB >> 21749386

Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air-liquid interface method for nasal drug transport study.

Hyun-Jong Cho1, Min-Koo Choi, Hongxia Lin, Jung Sun Kim, Suk-Jae Chung, Chang-Koo Shim, Dae-Duk Kim.   

Abstract

OBJECTIVES: P-glycoprotein (P-gp) is an efflux transporter encoded by the multidrug resistance gene (MDR1), which is also known as the human ABCB1 gene (ATP-binding cassette, subfamily-B). The objectives of this study were to investigate the expression of P-gp in passaged primary human nasal epithelial (HNE) cell monolayer, cultured by the air-liquid interface (ALI) method, and to evaluate its feasibility as an in-vitro model for cellular uptake and transport studies of P-gp substrates.
METHODS: Reverse transcriptase-polymerase chain reaction (RT-PCR) was performed to verify the expression of the MDR1 gene. Transport and cellular uptake studies with P-gp substrate (rhodamine123) and P-gp inhibitors (verapamil and cyclosporin A) were conducted to assess the functional activity of P-gp in HNE cell monolayers cultured by the ALI method. KEY
FINDINGS: MDR1 gene expression in primary HNE cell monolayers cultured by ALI method was confirmed by RT-PCR. The apparent permeability coefficient (P(app) ) of the P-gp substrate (rhodamine123) in the basolateral to apical (B to A) direction was 6.9 times higher than that in the apical to basolateral (A to B) direction. B to A transport was saturated at high rhodamine123 concentration, and the treatment of P-gp inhibitors increased cellular uptake of rhodamine123 in a time- and concentration-dependent manner.
CONCLUSIONS: These results support the MDR1 gene expression and the functional activity of P-gp in primary HNE cell monolayers cultured by the ALI method.
© 2011 The Authors. JPP © 2011 Royal Pharmaceutical Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21749386     DOI: 10.1111/j.2042-7158.2010.01221.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Current understanding of nasal morphology and physiology as a drug delivery target.

Authors:  Julie D Suman
Journal:  Drug Deliv Transl Res       Date:  2013-02       Impact factor: 4.617

2.  Microarray Determination of the Expression of Drug Transporters in Humans and Animal Species Used for the Investigation of Nasal Absorption.

Authors:  Manar Al-Ghabeish; Todd Scheetz; Mahfoud Assem; Maureen D Donovan
Journal:  Mol Pharm       Date:  2015-07-10       Impact factor: 4.939

3.  Effect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies.

Authors:  Satsuki Hashimoto; Kyoko Honda; Kohei Fujita; Yuka Miyachi; Kazuya Isoda; Ko Misaka; Yukio Suga; Satoshi Kato; Hiroyuki Tsuchiya; Yukio Kato; Masaki Okajima; Takumi Taniguchi; Tsutomu Shimada; Yoshimichi Sai
Journal:  J Pharm Health Care Sci       Date:  2018-11-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.